Clustered regularly interspaced short palindromic repeats, or for short
“CRISPR” is widely considered to be one of the biggest scientific and
medical advancements of the decade. This genome editing technology cuts DNA
sequences at specific genetic locations to alter it by either deleting an
old, or inserting a new sequence.The use-cases of this technology are near-limitless, as they can
change anything from a single base pair of DNA to big pieces of
chromosomes. Because DNA is at the base of many defects and diseases CRISPR
could be an easy way to get rid of complex issues.
“CRISPR” is widely considered to be one of the biggest scientific and
medical advancements of the decade. This genome editing technology cuts DNA
sequences at specific genetic locations to alter it by either deleting an
old, or inserting a new sequence.The use-cases of this technology are near-limitless, as they can
change anything from a single base pair of DNA to big pieces of
chromosomes. Because DNA is at the base of many defects and diseases CRISPR
could be an easy way to get rid of complex issues.
Cancer is one of these diseases that stem from a change in DNA, and
researchers now hope to find a new approach to fighting this threat by
altering these fraudulent DNA sequences. Other potential candidates for
CRISPR treatment include blood disorders, blindness, diabetes, HIV and many
more. “If trial data continue to be so positive, the treatment could be
approved as soon as 2023. “Bottom line, the progress of CRISPR/Vertex is a
landmark in that it’s likely to generate the first approved CRISPR-based
medicine,” says Fyodor Urnov, Ph., CRISPR Researcher at UC Berkeley.”
